Indicator of glycemic control over 2-3 months.
A form of hemoglobin resulting from non-enzymatic fixation of glucose on hemoglobin. It reflects average glycemic levels over 2-3 months.
Glycated hemoglobin, denoted HbA1c, forms when blood glucose binds to hemoglobin molecules. Unlike fluctuating glycemic levels, HbA1c represents a weighted average of glucose levels throughout the lifespan of red blood cells (120 days). A level below 5.7% is considered normal in non-diabetics, while a level between 5.7% and 6.4% indicates pre-diabetes. A level above 6.5% confirms diabetes diagnosis.
Enables diabetes diagnosis and monitoring by reflecting medium-term glycemic control.
Annual HbA1c dosage is recommended for high-risk individuals, and every 3 months for diabetics. Therapeutic targets typically range from 6.5% to 7.5% depending on patient profile.
HbA1c is the standard tool for evaluating long-term glycemic control.
A question about Glycated Hemoglobin? Ask our nutrition AI.
Ask a question